查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612864

软骨修復/软骨再生市场：依治疗模式、应用和最终用户划分－2025-2030年全球预测

Cartilage Repair/Cartilage Regeneration Market by Treatment Mode (Cell-Based, Non-Cell-Based), Application (Fibrocartilage, Hyaline Cartilage), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年软骨修復/软骨再生市场价值为18.3亿美元，预计2024年将达20.6亿美元，复合年增长率为13.55%，到2030年将达到44.6亿美元。

软骨修復和再生需要受损软骨组织的修復和再生，这对于关节功能和活动能力至关重要。骨关节炎、运动伤害和与老龄化相关的软骨损伤的流行推动了对此类手术的需求，这些疾病影响着数百万人，并推动了对有效治疗的需求。典型应用包括自体软骨细胞移植术、干细胞治疗和组织工程，最终使用者包括医院、整形外科诊所和研究机构。影响市场成长的主要因素包括再生医学的进步、医疗保健支出的增加以及对微创手术意识的增强。特别是，世界人口老化以及对更有效、侵入性较小的治疗的需求迅速增加，正在扩大该领域的机会。 3D 生物列印和生物工程支架的开发等技术创新是可促进产业显着成长的潜在机会。然而，治疗成本上涨、复杂的监管途径和报销问题等限制和挑战限制了市场的扩张。由于经济差异和缺乏熟练的专业人员，一些地区的采用率较低，这也加剧了这些挑战。最有希望创新的领域包括开发具有成本效益和扩充性的治疗方法以及提高修復的寿命和效率。企业应专注于持续调查方法，改进现有方法，并与学术和研究机构合作，保持在新发现的前沿。市场的本质是动态的，并由以患者为中心的创新和策略伙伴关係关係驱动，重点是个人化医疗。投资培训计划来应对人才挑战并促进全球合作可以提高您的竞争力。透过解决这些限制并抓住新机会，公司可以利用这个不断成长的市场。

主要市场统计
基准年[2023] 18.3亿美元
预计年份 [2024] 20.6亿美元
预测年份 [2030] 44.6亿美元
复合年增长率（%） 13.55%

市场动态：快速发展的软骨修復/软骨再生市场的关键市场洞察

软骨修復/软骨再生市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 关节炎、骨关节炎等骨关节疾病的流行
    • 交通事故和运动相关伤害迅速增加
    • 提高对软骨生理学、解剖学和修復技术的认识
  • 市场限制因素
    • 软骨修復手术相关的高成本
  • 市场机会
    • 软骨再生设备的技术进步
    • 持续研究和开发软骨再生
  • 市场挑战
    • 与软骨修復/软骨再生手术相关的风险和併发症

波特的五力：引领软骨修復/软骨再生市场的策略工具

波特五力是了解软骨修復/软骨再生市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解软骨修復/软骨再生市场的外部影响

外部宏观环境因素在塑造软骨修復/软骨再生市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解软骨修復/软骨再生市场的竞争状况

对软骨修復/软骨再生市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵软骨修復/软骨再生市场厂商绩效评估

FPNV定位矩阵是评估软骨修復/软骨再生市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製软骨修復/软骨再生市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对软骨修復/软骨再生市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 关节炎和骨关节炎等骨关节疾病的盛行率
      • 交通事故和运动相关伤害的数量正在迅速增加。
      • 提高对软骨生理学、解剖学和修復技术的认识
    • 抑制因素
      • 软骨修復手术相关的高成本
    • 机会
      • 软骨再生装置的技术进步
      • 持续研究和开发软骨再生
    • 任务
      • 与软骨修復/软骨再生手术相关的风险和併发症
  • 市场区隔分析
    • 治疗模式：年轻患者首选细胞治疗方法
    • 应用：更广泛地使用透明软骨疗法来实现有效的关节运动
    • 最终用户：由于复杂手术所需的先进设备和材料的存在，软骨修復/软骨再生在医院环境中的应用正在增加。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依治疗模式分類的软骨修復/软骨再生市场

  • 基于细胞的
    • 软骨细胞移植
    • 生长因子技术
  • 非细胞基础
    • 无细胞复合材料
    • 组织支架

第七章软骨修復/软骨再生市场：依应用分类

  • 纤维软骨
  • 透明软骨

第八章软骨修復/软骨再生市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 医院

第九章 北美和南美软骨修復/软骨再生市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太软骨修復/软骨再生市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲软骨修復/软骨再生市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 施乐辉获得用于运动医学膝盖修復的新软骨再生技术
    • FDA核准CartiHeal植入用于治疗软骨和骨软骨缺损
  • 战略分析和建议

公司名单

  • Anika Therapeutics Inc.
  • Arthrex GmbH
  • B. Braun SE
  • Collagen Solutions Ltd.
  • CONMED Corporation
  • Geistlich Pharma AG
  • Medical Device Business Services, Inc.
  • MEDIPOST Co., Ltd.
  • Orthocell Ltd.
  • Regrow Biosciences Pvt Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4103B31E00C5

The Cartilage Repair/Cartilage Regeneration Market was valued at USD 1.83 billion in 2023, expected to reach USD 2.06 billion in 2024, and is projected to grow at a CAGR of 13.55%, to USD 4.46 billion by 2030.

Cartilage repair and regeneration involve restoring or regrowing damaged cartilage tissue, crucial for joint function and mobility. The necessity for these procedures stems from the prevalence of osteoarthritis, sports injuries, and cartilage damage due to aging, which affect millions and drive demand for effective treatments. Applications primarily include autologous chondrocyte implantation, stem cell therapy, and tissue engineering, with end-users comprising hospitals, orthopedic clinics, and research institutes. Key factors influencing market growth include advancements in regenerative medicine, increasing healthcare expenditure, and rising awareness of minimally invasive procedures. Notably, the aging global population and burgeoning demand for more effective and less invasive treatments are expanding opportunities in this field. Technological innovations, such as 3D bioprinting and the development of bioengineered scaffolds, are potential opportunities that can be leveraged for significant industry growth. However, limitations and challenges such as the high cost of treatments, complex regulatory pathways, and reimbursement issues constrain market expansion. The slow adoption rate in some regions due to economic disparities and lack of skilled professionals further compounds these challenges. The most promising areas for innovation include developing cost-effective, scalable treatments and enhancing the longevity and efficiency of repairs. Companies should focus on continuous R&D to improve existing methodologies and collaborate with academic and research organizations to stay at the forefront of new discoveries. The nature of the market is dynamic, driven by patient-centric innovations and strategic partnerships, with an emphasis on personalized medicine. Investing in training programs to address human resource challenges and fostering global collaborations can provide a competitive edge. By addressing these constraints and seizing emerging opportunities, businesses can capitalize on this growing market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.83 billion
Estimated Year [2024] USD 2.06 billion
Forecast Year [2030] USD 4.46 billion
CAGR (%) 13.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cartilage Repair/Cartilage Regeneration Market

The Cartilage Repair/Cartilage Regeneration Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of bone and joint disorders such as arthritis or osteoarthritis
    • Surge in number of road accidents and sports-related injuries
    • Rising awareness about cartilage physiology, anatomy, and repair techniques
  • Market Restraints
    • High costs associated with cartilage repair surgeries
  • Market Opportunities
    • Technological advancements in cartilage regeneration equipment
    • Continuous research and development for cartilage regeneration
  • Market Challenges
    • Risks and complications involved in cartilage repair/cartilage regeneration procedures

Porter's Five Forces: A Strategic Tool for Navigating the Cartilage Repair/Cartilage Regeneration Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cartilage Repair/Cartilage Regeneration Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cartilage Repair/Cartilage Regeneration Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cartilage Repair/Cartilage Regeneration Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cartilage Repair/Cartilage Regeneration Market

A detailed market share analysis in the Cartilage Repair/Cartilage Regeneration Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cartilage Repair/Cartilage Regeneration Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cartilage Repair/Cartilage Regeneration Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cartilage Repair/Cartilage Regeneration Market

A strategic analysis of the Cartilage Repair/Cartilage Regeneration Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex GmbH, B. Braun SE, Collagen Solutions Ltd., CONMED Corporation, Geistlich Pharma AG, Medical Device Business Services, Inc., MEDIPOST Co., Ltd., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cartilage Repair/Cartilage Regeneration Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Mode, market is studied across Cell-Based and Non-Cell-Based. The Cell-Based is further studied across Chondrocyte Transplantation and Growth Factor Technology. The Non-Cell-Based is further studied across Cell-Free Composites and Tissue Scaffolds.
  • Based on Application, market is studied across Fibrocartilage and Hyaline Cartilage.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of bone and joint disorders such as arthritis or osteoarthritis
      • 5.1.1.2. Surge in number of road accidents and sports-related injuries
      • 5.1.1.3. Rising awareness about cartilage physiology, anatomy, and repair techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cartilage repair surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cartilage regeneration equipment
      • 5.1.3.2. Continuous research and development for cartilage regeneration
    • 5.1.4. Challenges
      • 5.1.4.1. Risks and complications involved in cartilage repair/cartilage regeneration procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Mode: Significant preference cell-based therapies for younger patients
    • 5.2.2. Application: Wider use of hyaline cartilage therapies for efficient joint movement
    • 5.2.3. End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cartilage Repair/Cartilage Regeneration Market, by Treatment Mode

  • 6.1. Introduction
  • 6.2. Cell-Based
    • 6.2.1. Chondrocyte Transplantation
    • 6.2.2. Growth Factor Technology
  • 6.3. Non-Cell-Based
    • 6.3.1. Cell-Free Composites
    • 6.3.2. Tissue Scaffolds

7. Cartilage Repair/Cartilage Regeneration Market, by Application

  • 7.1. Introduction
  • 7.2. Fibrocartilage
  • 7.3. Hyaline Cartilage

8. Cartilage Repair/Cartilage Regeneration Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Cartilage Repair/Cartilage Regeneration Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair
    • 12.3.2. FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anika Therapeutics Inc.
  • 2. Arthrex GmbH
  • 3. B. Braun SE
  • 4. Collagen Solutions Ltd.
  • 5. CONMED Corporation
  • 6. Geistlich Pharma AG
  • 7. Medical Device Business Services, Inc.
  • 8. MEDIPOST Co., Ltd.
  • 9. Orthocell Ltd.
  • 10. Regrow Biosciences Pvt Ltd.
  • 11. RTI Surgical, Inc.
  • 12. Smith & Nephew PLC
  • 13. Stryker Corporation
  • 14. Vericel Corporation
  • 15. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
  • FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023